Location: Home
  • search
  • go
  • Relate News
  • 7/8/2024China Expands Infectious Disease Direct Reporting System
  • 7/5/2024Recent Executive Moves
  • 7/2/2024Eisai and Biogen Launched Alzheimer's Drug LEQEMBI (Lecanemab) in Chin...
  • 7/2/2024BIOSECURE Act Impacts U.S. Biopharma Industry's Trust in Chinese Partn...
  • 7/2/2024Tracon's China-Approved Injectable Immune Checkpoint Inhibitor Faces S...
  • 7/2/2024HanAll and HBM Resubmits BLA for Myasthenia Gravis Treatment in China
  • 6/28/2024NHSA Issues the Working Plan and the Application Guide for Adjustment ...
  • 6/28/2024Recent Official and Executive Moves
  • 6/27/2024CASI Receives China Business Buyout Proposal from Its Chairman & CEO
  • 6/27/2024Novo Nordisk to Limit Wegovy Sales in China amid Supply Shortage
  • 6/27/2024Review of Chinese Hospital Drug Sales: Market Trends and Leading TCs
  • 6/27/2024Industry Braces for Biosecure Act Impact (C&EN)
  • 6/26/2024On Efficiency of China's Drug-Related Patent Term Compensation System ...
  • 6/25/2024Fosun to Take Henlius Biotech Private in HK$13.37B Bid
  • 6/25/2024NMPA Solicits Comments on Major Document on Optimizing the Review and ...
  • 6/25/2024Novo Nordisk's Wegovy Approved in China for Weight Loss
  • 6/24/2024Over 75% of Township Health Centers and Community Health Service Cente...
  • 6/21/2024Review of Chinese Pharmaceutical Market Segmentation 2019-2023
  • 6/21/2024Review of Chinese Drug Market Performance of Seven Leading MNCs 2016-2...
  • 6/21/2024Recent Official and Executive Moves
  • 6/20/2024Fosun to Reduce Its Stake in India's Gland Pharma
  • 6/20/2024Biocon Eyes China for Generic Diabetes and Weight-Loss Drug Trials
  • 6/20/2024Cheaper Versions of Blockbuster Obesity Drugs Are Being Created in Ind...
  • 6/19/2024Big Changes to China's BMI System Expected at 3rd Plenum (Pekingnology...
  • 6/19/2024Day One Biopharma Nabs ex-China Rights of MabCare's ADC MTX-13
  • 6/19/2024China Allocates More Urban Medical Resources to Lower-level Healthcare...
  • 6/18/2024China Biopharma Tracker – May 2024 (PharmaDJ)
  • 6/17/2024FDA Halts MediLink-BioNTech's ADC Trial After Three Fatalities
  • 6/14/2024Takeda, Ascentage Enter into Global License Deal for Olverembatinib
  • 6/14/2024Recent Official and Executive Moves
  • Page:25/356 Total number of articles:10656: [First][<<] [23] [24] [25] [26] [27] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group